CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hualan Biological Engineering Inc Company Snapshot
Hualan Biological Engineering Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hualan Biological Engineering Inc with three other companies in this sector in China: China Biologic Products, Inc. (2016 sales of 2.27 billion Chinese Renmimbi [US$329.46 million] of which 100% was Human Blood Product), Beijing Tiantan Biologic. (2.10 billion Chinese Renmimbi [US$304.13 million] of which 99% was Biological products industry), and Tonghua Dongbao Medicines Company Limited (2.03 billion Chinese Renmimbi [US$294.62 million] of which 96% was Pharmaceutical).

Sales Analysis. Hualan Biological Engineering Inc reported sales of 1.93 billion Chinese Renmimbi (US$280.73 million) for the year ending December of 2016. This represents an increase of 31.6% versus 2015, when the company's sales were 1.47 billion Chinese Renmimbi. Sales at Hualan Biological Engineering Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 101%). Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 66.8% in 2016, from 6.58 million Chinese Renmimbi to 10.97 million Chinese Renmimbi. Not all segments of Hualan Biological Engineering Inc experienced an increase in sales in 2016: sales of Vaccine Products fell 2.0% to 108.96 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hualan Biological Engineering Inc
  Stock Performance Chart for Hualan Biological Engineering Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 34.91
(Figures in Chinese Renmimbi)
1 Week 3.0%   13 Weeks -4.0%  
4 Weeks -0.5%   52 Weeks 14.6%  
 
Hualan Biological Engineering Inc Key Data:
  Ticker: 002007 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 1,934,181,170
(Year Ending Jan 2017).
Employees: 1,718
  Currency: Chinese Renmimbi Market Cap: 32,469,360,909
  Fiscal Yr Ends: December Shares Outstanding: 930,087,680
  Share Type: A Shares Closely Held Shares: 506,382,649
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.